Mathieu Schmitt
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery 1
-
- Neuroscience and Neuropharmacology Research 2
- Nuclear Receptors and Signaling 2
-
- Cancer therapeutics and mechanisms 1
- Prion Diseases and Protein Misfolding 1
-
- Cholesterol and Lipid Metabolism 1
-
- Cryptography and Data Security 1
-
- Renal cell carcinoma treatment 1
Mathieu Schmitt
7 papers receiving 296 citations
Peers
Comparison fields: 5 of 53
- Pharmaceutical Science 85
- Neurology 51
- Physiology 110
- Public Health, Environmental and Occupational Health 100
- Biological Psychiatry 8
Countries citing papers authored by Mathieu Schmitt
This map shows the geographic impact of Mathieu Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Schmitt more than expected).
Fields of papers citing papers by Mathieu Schmitt
This network shows the impact of papers produced by Mathieu Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Schmitt. The network helps show where Mathieu Schmitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mathieu Schmitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 6 | |
| 3 | 2019 | 127 | |
| 4 | 2017 | 0 | |
| 5 | 2017 | 139 | |
| 6 | 2017 | 7 | |
| 7 | 2015 | 14 | |
| 8 | Architecture de sécurité pour les données dans un contexte d'informatique en nuage | 2014 | 0 |
| 9 | [Acquired cystic kidney disease and autosomal dominant polycystic kidney disease--precancerous condition?]. | 1989 | 1 |
About Mathieu Schmitt
Mathieu Schmitt is a scholar working on Discrete Mathematics and Combinatorics, Cellular and Molecular Neuroscience and Pharmaceutical Science, having authored 9 papers that have together received 299 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (2 papers), Nuclear Receptors and Signaling (2 papers), Cancer therapeutics and mechanisms (1 paper), Cholesterol and Lipid Metabolism (1 paper), Advancements in Transdermal Drug Delivery (1 paper), Cryptography and Data Security (1 paper), Prion Diseases and Protein Misfolding (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Pharmaceutical Science (85 citations), Neurology (51 citations) and Physiology (110 citations). Mathieu Schmitt has collaborated with scholars based in France, Belgium and Austria. Frequent co-authors include Jean‐Louis Bourges, Frédéric Lallemand, Robert Gurny, Simon Benita, Jean‐Sébastien Garrigue, Georges Mairet‐Coello, Raphaëlle Caillierez, Jean‐Philippe Courade, Luc Buée and Patrick Downey. Their work appears in journals such as Brain, European Journal of Pharmaceutics and Biopharmaceutics and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.